心肌纤维化
体内
细胞外基质
细胞生物学
下调和上调
转化生长因子
心力衰竭
拮抗剂
基因敲除
化学
作者
Lichan Tao,Yihua Bei,Ping Chen,Zhiyong Lei,Siyi Fu,Haifeng Zhang,Jiahong Xu,Lin Che,Xiongwen Chen,Joost P.G. Sluijter,Saumya Das,Dragos Cretoiu,Bin Xu,Jiuchang Zhong,Junjie Xiao,Xinli Li
出处
期刊:Theranostics
[Ivyspring International Publisher]
日期:2016-09-10
卷期号:6 (12): 2068-2083
被引量:86
摘要
Dysregulation of microRNAs has been implicated in many cardiovascular diseases including fibrosis. Here we report that miR-433 was consistently elevated in three models of heart disease with prominent cardiac fibrosis, and was enriched in fibroblasts compared to cardiomyocytes. Forced expression of miR-433 in neonatal rat cardiac fibroblasts increased proliferation and their differentiation into myofibroblasts as determined by EdU incorporation, α-SMA staining, and expression levels of fibrosis-associated genes. Conversely, inhibition of miR-433 exhibited opposite results. AZIN1 and JNK1 were identified as two target genes of miR-433. Decreased level of AZIN1 activated TGF-β1 while down-regulation of JNK1 resulted in activation of ERK and p38 kinase leading to Smad3 activation and ultimately cardiac fibrosis. Importantly, systemic neutralization of miR-433 or adeno-associated virus 9 (AAV9)-mediated cardiac transfer of a miR-433 sponge attenuated cardiac fibrosis and ventricular dysfunction following myocardial infarction. Thus, our work suggests that miR-433 is a potential target for amelioration of cardiac fibrosis.
科研通智能强力驱动
Strongly Powered by AbleSci AI